Doxylamine Succinate; Pyridoxine Hydrochloride Patent Expiration
Doxylamine Succinate; Pyridoxine Hydrochloride is Used for treating nausea and vomiting of pregnancy in women who do not respond to conservative management. It was first introduced by Sanofi Aventis Us Llc
Doxylamine Succinate; Pyridoxine Hydrochloride Patents
Given below is the list of patents protecting Doxylamine Succinate; Pyridoxine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Bonjesta | US9089489 | Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof | Feb 18, 2033 | Duchesnay |
| Bonjesta | US9375404 | Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof | Feb 18, 2033 | Duchesnay |
| Bonjesta | US9526703 | Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof | Feb 18, 2033 | Duchesnay |
| Bonjesta | US9937132 | Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof | Feb 18, 2033 | Duchesnay |
| Diclegis | US6340695 | Rapid onset formulation |
Jun 21, 2021
(Expired) | Duchesnay |
| Bonjesta | US7560122 | Pharmaceutical dosage form bearing pregnancy-friendly indicia |
Jan 25, 2019
(Expired) | Duchesnay |
| Diclegis | US7560122 | Pharmaceutical dosage form bearing pregnancy-friendly indicia |
Jan 25, 2019
(Expired) | Duchesnay |
Doxylamine Succinate; Pyridoxine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List